Učitavanje...
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
Hypertension is particularly prevalent in patients aged ⩾65 years, those with a body mass index ⩾30 kg m(−2), Blacks and those with type II diabetes. Here we report a prespecified secondary analysis of the efficacy of amlodipine (10 mg day(−1)), olmesartan medoxomil (40 mg day(−1)), a combination of...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2010
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2963900/ https://ncbi.nlm.nih.gov/pubmed/20164847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jhh.2010.5 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|